Holen Sie sich die Stockscreener-App
6.97
1.16%
0.08
Handel nachbörslich:
6.85
-0.12
-1.72%
Schlusskurs vom Vortag:
$6.89
Offen:
$6.93
24-Stunden-Volumen:
135.54K
Relative Volume:
0.62
Marktkapitalisierung:
$269.91M
Einnahmen:
$128.45M
Nettoeinkommen (Verlust:
$6.54M
KGV:
139.40
EPS:
0.05
Netto-Cashflow:
$-8.79M
1W Leistung:
-4.39%
1M Leistung:
+11.88%
6M Leistung:
+3.41%
1J Leistung:
+6.09%
1-Tages-Spanne:
$6.79
$7.00
1-Wochen-Bereich:
$6.73
$7.43
52-Wochen-Spanne:
$3.6793
$7.99
Lifecore Biomedical Inc Stock (LFCR) Company Profile
Firmenname
Lifecore Biomedical Inc
Sektor
Telefon
(952) 368-4300
Adresse
3515 LYMAN BOULEVARD, CHASKA
Vergleichen Sie LFCR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
6.97 | 269.91M | 128.45M | 6.54M | -8.79M | 0.05 |
|
ZTS
Zoetis Inc
|
159.27 | 70.23B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.74 | 48.23B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.36 | 48.22B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.93 | 18.57B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
301.42 | 13.29B | 2.76B | 1.11B | 898.10M | 22.77 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-09-05 | Eingeleitet | Craig Hallum | Buy |
| 2024-08-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2023-03-20 | Herabstufung | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc Aktie (LFCR) Neueste Nachrichten
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Reach Out - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Lifecore Biomedical, Inc.'s (NASDAQ:LFCR) hedge funds shareholders had a great week as one-year returns increased after a 11% gain last week - Yahoo Finance
A Piece Of The Puzzle Missing From Lifecore Biomedical, Inc.'s (NASDAQ:LFCR) Share Price - simplywall.st
Press Release Distribution & PR Platform - ACCESS Newswire
Geode Capital Management LLC Raises Stock Holdings in Lifecore Biomedical, Inc. (NASDAQ:LFCR) - Defense World
When the Price of (LFCR) Talks, People Listen - news.stocktradersdaily.com
Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference - The Manila Times
Quality Management Expert from Lifecore to Chair Strategic Discussion at Major CDMO Conference - Stock Titan
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - markets.businessinsider.com
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Lifecore Appoints Top Legal Executive: Stock Price Targets Set at 5x Current Value - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Stockholders to Learn More About the Investigation - markets.businessinsider.com
Lifecore Biomedical Taps Thomas Salus as Chief Legal & Administration Officer - Contract Pharma
Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer - GlobeNewswire
Lifecore Strengthens Leadership: Former Viatris Legal Chief Joins to Drive Strategic Growth - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Investors to Inquire about Securities Investigation - markets.businessinsider.com
Prudential Financial Inc. Makes New $95,000 Investment in Lifecore Biomedical, Inc. (NASDAQ:LFCR) - Defense World
Lifecore Biomedical secures stockholder nod for share issuance - Investing.com Australia
Lifecore Biomedical secures stockholder nod for share issuance By Investing.com - Investing.com South Africa
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Reach Out - markets.businessinsider.com
LFCR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Lifecore Biomedical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Lifecore Biomedical, Inc. Under Investigation: Schall Law Firm Encourages Investors with Losses to Reach Out - ACCESS Newswire
Hedge funds owners may consider drastic measures as Lifecore Biomedical, Inc.'s (NASDAQ:LFCR) recent US$65m drop adds to long-term losses - simplywall.st
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Connect - markets.businessinsider.com
(LFCR) Investment Analysis - news.stocktradersdaily.com
Lifecore Biomedical’s Earnings Call: Strategic Optimism Amid Challenges - MSN
Lifecore Biomedical Third Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q3 2025 Earnings Call Transcript - Insider Monkey
Sector Update: Health Care Stocks Fall Late Afternoon - MarketScreener
Top Midday Decliners - MarketScreener
Lifecore Biomedical earnings missed by $0.33, revenue topped estimates - Investing.com Canada
Lifecore Biomedical Inc (LFCR) Q3 2025 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Reach Out - ACCESS Newswire
Lifecore Biomedical Reports Q3 Fiscal 2025 Results - TipRanks
Lifecore Biomedical (LFCR) Maintains Outlook Amid Strategic Grow - GuruFocus
Lifecore Biomedical targets 12% revenue CAGR and expanded CDMO pipeline by 2027 - MSN
Lifecore Biomedical: Fiscal Q3 Earnings Snapshot - MySA
Lifecore Biomedical (LFCR) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results - MarketScreener
Lifecore Biomedical Inc reports results for the quarter ended February 28Earnings Summary - TradingView
Finanzdaten der Lifecore Biomedical Inc-Aktie (LFCR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.82%
1.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):